home > drugs a-z list > striant (testosterone) drug center > striant (testosterone) drug - overdosage and contraindications

There is one report of acute overdosage with testosterone enanthate injection: testosterone levels of up to 11,400 ng/dL were implicated in a cerebrovascular accident.

Oral ingestion of Striant® (testosterone) is not expected to result in clinically significant serum testosterone concentrations due to extensive first-pass (hepatic) metabolism.

Androgens are contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate.

Striant® (testosterone) is not indicated for use in women, and must not be used in women. Testosterone supplements may cause fetal harm.

Striant® (testosterone) should not be used in patients with known hypersensitivity to any of its ingredients, including testosterone USP that is chemically synthesized from soy.

Last reviewed on RxList: 5/19/2009
This monograph has been modified to include the generic and brand name in many instances.